Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$467M |
| 2 |
CRH
CRH
|
+$449M |
| 3 |
Broadcom
AVGO
|
+$446M |
| 4 |
Philip Morris
PM
|
+$414M |
| 5 |
Kenvue
KVUE
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$494M |
| 2 |
ExxonMobil
XOM
|
+$443M |
| 3 |
Visa
V
|
+$433M |
| 4 |
Merck
MRK
|
+$402M |
| 5 |
Advanced Micro Devices
AMD
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.89% |
| 2 | Healthcare | 11.83% |
| 3 | Financials | 11.72% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KWY
3551
Kingsway Corp
KWY
$254M
| $120K | ﹤0.01% |
+15,938
| New | +$133K |
|
|
SVM
3552
Silvercorp Metals
SVM
$2.02B
| $120K | ﹤0.01% |
51,195
-1,529
| -3% | -$4.15K |
|
|
YI
3553
111 Inc
YI
$31.3M
| $119K | ﹤0.01% |
+4,584
| New | +$129K |
|
|
RAD
3554
DELISTED
Rite Aid Corporation
RAD
| $118K | ﹤0.01% |
262,852
-2,884
| -1% | -$3.87K |
|
3555
AST SpaceMobile
ASTS
$15.8B
| $118K | ﹤0.01% |
30,941
| – | – |
|
3556
Arbutus Biopharma
ABUS
$847M
| $115K | ﹤0.01% |
56,615
+3,075
| +6% | +$6.45K |
|
3557
DHI Group
DHX
$177M
| $114K | ﹤0.01% |
37,373
+20,256
| +118% | +$72.3K |
|
3558
ThredUp
TDUP
$765M
| $113K | ﹤0.01% |
28,080
| – | – |
|
3559
Axogen
AXGN
$2.2B
| $112K | ﹤0.01% |
22,365
+1,375
| +7% | +$9.52K |
|
|
NBP
3560
NovaBridge Biosciences American Depositary Shares
NBP
$186M
| $111K | ﹤0.01% |
84,162
+9,225
| +12% | +$20.3K |
|
|
SGMO
3561
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $111K | ﹤0.01% |
184,879
+5,597
| +3% | +$5.99K |
|
3562
China Automotive Systems
CAAS
$131M
| $110K | ﹤0.01% |
28,359
+708
| +3% | +$3.27K |
|
|
ENFN
3563
DELISTED
Enfusion, Inc.
ENFN
| $110K | ﹤0.01% |
12,247
+2,147
| +21% | +$20.4K |
|
|
ERH
3564
Allspring Utilities & High Income Fund
ERH
$104M
| $107K | ﹤0.01% |
12,288
-2,729
| -18% | -$26.9K |
|
3565
Rush Street Interactive
RSI
$3.17B
| $107K | ﹤0.01% |
23,196
| – | – |
|
3566
C4 Therapeutics
CCCC
$389M
| $105K | ﹤0.01% |
56,391
+481
| +0.9% | +$1.47K |
|
|
HLTH
3567
DELISTED
Cue Health Inc. Common Stock
HLTH
| $105K | ﹤0.01% |
237,069
+2,021
| +0.9% | +$922 |
|
|
CGC
3568
Canopy Growth
CGC
$376M
| $104K | ﹤0.01% |
13,277
-417
| -3% | -$2.55K |
|
3569
Scholar Rock
SRRK
$5.88B
| $103K | ﹤0.01% |
14,563
+2,121
| +17% | +$14.3K |
|
3570
Seres Therapeutics
MCRB
$45M
| $103K | ﹤0.01% |
2,168
+113
| +5% | +$8.62K |
|
|
NXDT
3571
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $103K | ﹤0.01% |
11,833
| – | – |
|
3572
Compañía de Minas Buenaventura
BVN
$7.68B
| $103K | ﹤0.01% |
12,034
| – | – |
|
|
CBH
3573
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
| $102K | ﹤0.01% |
11,611
+447
| +4% | +$3.89K |
|
|
JOAN
3574
DELISTED
JOANN, Inc. Common Stock
JOAN
| $102K | ﹤0.01% |
140,990
+1,104
| +0.8% | +$1.17K |
|
3575
PDS Biotechnology
PDSB
$37.4M
| $101K | ﹤0.01% |
19,916
+2,166
| +12% | +$11.9K |
|
Similar funds
Invesco's Q3 2023 Portfolio in Review
As of Q3 2023, Invesco held 3,966 positions worth $371B, down 2.7% from $381B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Invesco's Q3 2023 filing shows 118 new, 2,175 increased, 1,355 reduced and 98 closed positions. Its largest new stake was Stellantis: 12,130,006 shares worth $232M. The largest sale was Microsoft, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q3 2023 buy was Stellantis: 12,130,006 shares worth $232M.
- Invesco added most to Adobe in Q3 2023, an estimated $467M increase.
- Invesco's biggest Q3 2023 reduction was Microsoft, cutting an estimated $494M.
- Invesco fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $272M.
- Invesco's ten largest holdings make up 14% of its $371B portfolio in Q3 2023.
- Invesco opened 118 new positions and closed 98 in Q3 2023.
- Invesco's portfolio value fell 2.7% quarter-over-quarter to $371B.
Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.